FDA NDC Directory · JSON-LD · Markdown

Thiotepa

NDC 65219-029 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA214222
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRACAVITARY INTRAVENOUS INTRAVESICAL
Active ingredientsTHIOTEPA (100 mg/1)
Marketing started20220411
Package count1

External sources

Source: openFDA. Public-domain (CC0).